Evidence map›Paper›PMID 40193190›Full record

Observational studyJMIR research protocols2025

Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective Observational Study.

Deborah A Hall, Josh M Shulman, Andrew Singleton, Sara Bandres Ciga, Michelle Hyczy S Tosin, Bichun Ouyang, Lisa Shulman

Abstract readObservational Study
In one paragraph

Observational study in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Deborah A HallDepartment of Neurological Sciences, Rush University, Chicago, IL, United States.ORCID 0000-0003-2772-7851
Josh M ShulmanDepartments of Neurology and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.ORCID 0000-0002-1835-1971
Andrew SingletonLaboratory of Neurogenetics, National Institutes of Aging, National Institutes of Health, Bethesda, MD, United States.ORCID 0000-0001-5606-700X
Sara Bandres CigaLaboratory of Neurogenetics, National Institutes of Aging, National Institutes of Health, Bethesda, MD, United States.ORCID 0000-0003-0056-1361
Michelle Hyczy S TosinDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States.ORCID 0000-0001-7309-1407
Bichun OuyangDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States.ORCID 0000-0002-0452-7219
Lisa ShulmanDepartment of Neurology, University of Maryland School of Medicine, University of Maryland, Baltimore, MD, United States.ORCID 0000-0002-1652-1201

Funding

Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and GeneticsR01NS125294 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI DEBORAH A HALL, LISA M. SHULMAN · 2022 to 2026
$3.2M
NINDS NIH HHS R01 NS125294
6 · The paper itself

Abstract

backgroundParkinson disease (PD) has been described and studied extensively in White populations, with little known about how the disease manifests and progresses in patients from the Black community. Studies investigating disease features in Black populations are uncommon, with some suggesting that the Black population with PD is more disabled and has greater disease severity and different clinical features compared with the White population with PD. These health disparities are likely to influence the quality of care for Black patients with PD.

objectiveThis study aimed to investigate the motor and nonmotor symptoms and quality of life in Black and White participants with PD in a case-case design.

methodsThis is an observational, prospective, multicenter, case-case design study. Other aims will investigate the management of PD in Black individuals and the presence of shared or unique genetic risk factors among the Black PD population. A total of 400 Black and 200 White participants with PD will be recruited. Data will be collected at 7 US sites and entered into a Research Electronic Data Capture database. Linear multivariate regression analysis will be used, except for comparing PD management, which will be analyzed using the chi-square test or Fisher exact test. Bonferroni correction will be applied. This protocol also describes plans for educational programming for clinicians and patients at the end of the study in partnership with national PD organizations.

resultsThe Rush Institutional Review Board approved the project as the single-site institutional review board in February 2022, and it was funded by the National Institute of Neurological Disorders and Stroke in April 2022. Recruitment began in July 2022. At the time of submission of this manuscript, 131 participants had been recruited.

conclusionsTo our knowledge, this is the largest study of PD phenotype and management in Black patients in the United States. The planned collaboration with the Global Parkinson's Genetics Program and PD GENEration will enhance our understanding of genetic risk factors for PD in this understudied population. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/60587.

Indexed as

Healthcare DisparitiesHealth Status DisparitiesParkinson DiseaseAgedBlack or African AmericanFemaleHumansMaleMiddle AgedObservational Studies as TopicPhenotypeProspective StudiesQuality of LifeUnited StatesWhiteclinical protocolgenetic risk factorshealth disparitiesParkinson diseasequality of carequality of liferacial disparities

Identifiers

PMID40193190
PMCPMC12012400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.